What Key Growth Drivers Are Shaping The Peripheral Neuropathy Market Forecast Toward $7.24 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Peripheral Neuropathy Market Today And What Is Its Future Size?
The market for peripheral neuropathy has seen swift expansion in the past few years. It is projected to escalate from $4.09 billion in 2024 to $4.59 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.2%. The historical growth is a result of several factors including a higher incidence of chronic ailments like diabetes, increased awareness around managing neuropathic pain, a surge in global elderly population, improved healthcare infrastructure, the presence of dedicated treatment facilities, government steps towards enhancing neurologic healthcare service, and the adoption of innovative treatment alternatives.
In the upcoming years, the peripheral neuropathy market is set to experience a swift expansion. The market size is predicted to reach $7.24 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 12.1%. This projected growth within the forecast period can be due to several factors including, the increasing prevalence of chronic illnesses like cancer and diabetes, the advancement in pharmacological treatments targeting neuropathic pain pathways, increased funding towards research and development of innovative treatment methods, the integration of digital health solutions for remote monitoring and personal management of neuropathic symptoms, an intensified focus on patient-centric care models, and more accessible multidisciplinary healthcare services. In the forecast period, notable trends include the increased uptake of personalized treatment, the rise in the application of wearable devices for immediate tracking of neuropathic symptoms and treatment, the broadening of telemedicine services for distant consultations and follow-ups, the creation of targeted therapies dealing with specific neuropathic pain pathways and mechanisms, advancements in regenerative medicine techniques, the incorporation of digital therapeutics platforms for cognitive behavioral therapy, mindfulness-based interventions and technological advancements in the diagnostic tools used in the early detection and monitoring of peripheral neuropathy.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16507&type=smp
Which Demand Drivers Are Strengthening The Peripheral Neuropathy Market?
The proliferation of diabetes is anticipated to fuel the expansion of the peripheral neuropathy market. Diabetes is a long-term health condition that results in unusually high glucose in the blood due to the body’s failure to either produce or adequately utilize insulin. The growing number of diabetes cases is predominantly attributed to factors such as an increase in obesity rates, sedentary lifestyle habits, and an aging demographic. Diabetes can provoke peripheral neuropathy by inflicting damage to the nerves as a response to extended periods of elevated blood sugar, causing symptoms such as discomfort, prickling sensation, and numbness in the limbs. Proper regulation of blood sugar is essential to avoid or slow down the development of this complication. For example, a report released by The British Diabetic Association in April 2023 showed that 4.3 million individuals in the UK have been diagnosed with diabetes. Registration data for 2021-22 reveals a surge of 148,951 cases relative to 2020-21. Moreover, over 2.4 million residents in the UK are extremely susceptible to acquiring type 2 diabetes. Thus, the escalating prevalence of diabetes is stimulating the growth of the peripheral neuropathy market.
Which Segment Accounts For The Largest Share In The Peripheral Neuropathy Market?
The peripheral neuropathymarket covered in this report is segmented –
1) By Type: Chemotherapy-Induced; Diabetic; Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS Associated; Idiopathic
2) By Diagnosis: Blood Test; Biopsy; Imaging; Other Diagnosis
3) By Treatment: Medications; Antidepressants; Anti-Seizure Medication; Pain Reliever; Topical Treatment; Therapies; Nerve Stimulation; Plasma Exchange; Physical Therapy; Other Treatments
4) By End-User: Hospitals; Clinics; Ambulatory Centers
Subsegments:
1) By Chemotherapy-Induced: Taxane-Induced Peripheral Neuropathy; Platinum-Based Drug-Induced Neuropathy; Other Chemotherapy-Induced Neuropathies
2) By Diabetic: Type 1 Diabetes-Induced Peripheral Neuropathy; Type 2 Diabetes-Induced Peripheral Neuropathy
3) By Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS) Associated: HIV-Associated Peripheral Neuropathy; AIDS-Related Peripheral Neuropathy
4) By Idiopathic: Acute Idiopathic Neuropathy; Chronic Idiopathic Neuropathy
Which Long-Term Trends Will Play A Crucial Role In The Peripheral Neuropathy Market?
Leading businesses in the peripheral neuropathy market are concentrated on introducing enhanced solutions like point-of-care appliances to refine the identification and treatment of the problem. A prompt quantitative screening test for peripheral neuropathy at the point-of-care is an examination method used to rapidly identify any nerve damage in an individual’s limbs, especially in diabetes patients. For example, in January 2023, NeuroMetrix Inc., a producer of non-invasive medical equipment based in the US, released a point-of-care instrument called DPNCheck 2.0 for the detection of peripheral neuropathy. This device employs nerve conduction technology to determine the systematic deterioration of peripheral nerves that can cause severe conditions like diabetic peripheral neuropathy (DPN). It provides swift patient screening by measuring peripheral nerve function quantitatively, making it a more precise and efficient means than conventional methods such as tuning fork and monofilament tests.
Which Companies Hold A Competitive Edge In The 1083 Market?
Major companies operating in the peripheral neuropathy market are Pfizer Inc., Merck and Co. Inc., Novartis AG, Bristol Myers Squibb Co, AstraZeneca Plc, Abbott Laboratories, Eli Lilly and Co., Asahi Kasei Corporation, Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Cadila Pharmaceuticals Ltd., Dr. Reddy’s Laboratories, Cipla Ltd., Apotex Inc, Hikma Pharmaceuticals PLC, Lupin Limited, Grunenthal GmbH, ACI Limited, Lexicon Pharmaceuticals, Solasia Pharma KK, Helixmith Co. Ltd., PledPharma AB
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report
Which Region Is Forecasted To Lead The Peripheral Neuropathy Market In The Coming Years?
North America was the largest region in the peripheral neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=16507&type=smp
Browse Through More Reports Similar to the Global Peripheral Neuropathy Market 2025, By The Business Research Company
Nephrology And Urology Devices Global Market Report 2025
Injection Molding Machine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/injection-molding-machine-global-market-report
Gasoline Direct Injection Gdi Device Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
